Skip to main content

Table 1 Demographic and clinical characteristics of healthy controls and nonalcoholic fatty liver disease patients

From: Combining I148M and E167K variants to improve risk prediction for nonalcoholic fatty liver disease in Qingdao Han population, China

N

Healthy controls

NAFLD patients

t

P value

451

512

  

BMI(kg/m^2)

22.48 ± 3.12

26.71 ± 2.81

−21.967

0.000

ALB (g/L)

46.78 ± 2.31

46.28 ± 2.84

2.980

0.003

FPG (mmol/L)

4.69 ± 2.67

4.99 ± 1.28

−2.219

0.027

ALT (U/L)

20.11 ± 15.07

36.98 ± 23.78

−13.300

0.000

AST (U/L)

21.06 ± 8.91

26.34 ± 11.33

−8.081

0.000

GGT (U/L)

24.20 ± 23.73

46.79 ± 35.02

−11.833

0.000

ALP (U/L)

62.19 ± 15.43

77.00 ± 26.29

−10.808

0.000

TG (mmol/L)

1.20 ± 1.04

2.16 ± 1.64

−11.021

0.000

TC (mmol/L)

5.18 ± 0.88

5.49 ± 1.12

−4.690

0.000

HDL (mmol/L)

1.42 ± 0.29

1.25 ± 0.24

9.529

0.000

LDL (mmol/L)

2.93 ± 0.69

3.70 ± 1.26

−11.423

0.000

UA (mmol/L)

309.16 ± 74.02

401.13 ± 88.05

−17.545

0.000

  1. Abbreviations: NAFLD nonalcoholic fatty liver disease, BMI body mass index, ALB albumin, FPG fasting plasma glucose, ALT alanine aminotransferase, AST aspartate aminotransferase, GGT γ-glutamyltransferase, ALP alkaline phosphatase, TG Triglyceride, TC total cholesterol, HDL high-density lipoprotein, LDL low-density lipoprotein, UA uric acid